Market Place
Sourcing Support
All News #Library
Biotech
ERS Genomics Launches New Early Access Express License
24 Feb 2026 //
PR NEWSWIRE
ERS Genomics, Dyadic Biosolutions Ink CRISPR/Cas9 License Deal
10 Nov 2025 //
PR NEWSWIRE
ERS Genomics Launches ‘Express License’ For CRISPR/Cas9 Access
13 Jan 2025 //
GLOBENEWSWIRE
ERS Genomics and Medicines Discovery Catapult Sign CRISPR/Cas9 License Agreement
04 Sep 2024 //
BUSINESSWIRE
ERS Genomics and IRBM Sign CRISPR/Cas9 License Agreement
20 May 2024 //
BUSINESSWIRE
ERS Genomics Appoints John E Milad as Chief Executive Officer
13 May 2024 //
BUSINESSWIRE
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement
18 Sep 2023 //
PR NEWSWIRE
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement
14 Sep 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.